These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1229 related articles for article (PubMed ID: 24352696)
1. MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects. Long JM; Ray B; Lahiri DK J Biol Chem; 2014 Feb; 289(8):5184-98. PubMed ID: 24352696 [TBL] [Abstract][Full Text] [Related]
2. Circulating Small Extracellular Vesicle-Derived miR-342-5p Ameliorates Beta-Amyloid Formation via Targeting Beta-site APP Cleaving Enzyme 1 in Alzheimer's Disease. Dong Z; Gu H; Guo Q; Liu X; Li F; Liu H; Sun L; Ma H; Zhao K Cells; 2022 Nov; 11(23):. PubMed ID: 36497090 [TBL] [Abstract][Full Text] [Related]
3. miR-15b reduces amyloid-β accumulation in SH-SY5Y cell line through targetting NF-κB signaling and BACE1. Li J; Wang H Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29961672 [TBL] [Abstract][Full Text] [Related]
4. miR-186 is decreased in aged brain and suppresses BACE1 expression. Kim J; Yoon H; Chung DE; Brown JL; Belmonte KC; Kim J J Neurochem; 2016 May; 137(3):436-45. PubMed ID: 26710318 [TBL] [Abstract][Full Text] [Related]
5. Down-regulated expression of microRNA-338-5p contributes to neuropathology in Alzheimer's disease. Qian Q; Zhang J; He FP; Bao WX; Zheng TT; Zhou DM; Pan HY; Zhang H; Zhang XQ; He X; Sun BG; Luo BY; Chen C; Peng GP FASEB J; 2019 Mar; 33(3):4404-4417. PubMed ID: 30576233 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-153 physiologically inhibits expression of amyloid-β precursor protein in cultured human fetal brain cells and is dysregulated in a subset of Alzheimer disease patients. Long JM; Ray B; Lahiri DK J Biol Chem; 2012 Sep; 287(37):31298-310. PubMed ID: 22733824 [TBL] [Abstract][Full Text] [Related]
7. miR-98-5p Acts as a Target for Alzheimer's Disease by Regulating Aβ Production Through Modulating SNX6 Expression. Li Q; Li X; Wang L; Zhang Y; Chen L J Mol Neurosci; 2016 Dec; 60(4):413-420. PubMed ID: 27541017 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-195 downregulates Alzheimer's disease amyloid-β production by targeting BACE1. Zhu HC; Wang LM; Wang M; Song B; Tan S; Teng JF; Duan DX Brain Res Bull; 2012 Sep; 88(6):596-601. PubMed ID: 22721728 [TBL] [Abstract][Full Text] [Related]
9. APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease. Bettens K; Brouwers N; Engelborghs S; Van Miegroet H; De Deyn PP; Theuns J; Sleegers K; Van Broeckhoven C Hum Mutat; 2009 Aug; 30(8):1207-13. PubMed ID: 19462468 [TBL] [Abstract][Full Text] [Related]
10. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease. Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613 [TBL] [Abstract][Full Text] [Related]
11. The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. Wang WX; Rajeev BW; Stromberg AJ; Ren N; Tang G; Huang Q; Rigoutsos I; Nelson PT J Neurosci; 2008 Jan; 28(5):1213-23. PubMed ID: 18234899 [TBL] [Abstract][Full Text] [Related]
12. Evidence for natural antisense transcript-mediated inhibition of microRNA function. Faghihi MA; Zhang M; Huang J; Modarresi F; Van der Brug MP; Nalls MA; Cookson MR; St-Laurent G; Wahlestedt C Genome Biol; 2010; 11(5):R56. PubMed ID: 20507594 [TBL] [Abstract][Full Text] [Related]
13. Effects of Folic Acid on Secretases Involved in Aβ Deposition in APP/PS1 Mice. Tian T; Bai D; Li W; Huang GW; Liu H Nutrients; 2016 Sep; 8(9):. PubMed ID: 27618097 [TBL] [Abstract][Full Text] [Related]
14. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Hébert SS; Horré K; Nicolaï L; Papadopoulou AS; Mandemakers W; Silahtaroglu AN; Kauppinen S; Delacourte A; De Strooper B Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6415-20. PubMed ID: 18434550 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease. Liu CG; Wang JL; Li L; Wang PC Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165 [TBL] [Abstract][Full Text] [Related]
16. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis. Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065 [TBL] [Abstract][Full Text] [Related]
17. Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease. Lei X; Lei L; Zhang Z; Zhang Z; Cheng Y Int J Clin Exp Pathol; 2015; 8(2):1565-74. PubMed ID: 25973041 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties. Chopra N; Wang R; Maloney B; Nho K; Beck JS; Pourshafie N; Niculescu A; Saykin AJ; Rinaldi C; Counts SE; Lahiri DK Mol Psychiatry; 2021 Oct; 26(10):5636-5657. PubMed ID: 31942037 [TBL] [Abstract][Full Text] [Related]
19. MiR-16 attenuates β-amyloid-induced neurotoxicity through targeting β-site amyloid precursor protein-cleaving enzyme 1 in an Alzheimer's disease cell model. Zhong Z; Yuan K; Tong X; Hu J; Song Z; Zhang G; Fang X; Zhang W Neuroreport; 2018 Nov; 29(16):1365-1372. PubMed ID: 30142113 [TBL] [Abstract][Full Text] [Related]
20. miR-34a-5p and miR-125b-5p attenuate Aβ-induced neurotoxicity through targeting BACE1. Li P; Xu Y; Wang B; Huang J; Li Q J Neurol Sci; 2020 Jun; 413():116793. PubMed ID: 32251872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]